Injectable Drug Delivery Market by Type (Device, Formulation), Therapeutic (Cancer), Usage Pattern (Immunization), Administration (Skin, Musculoskeletal), Distribution Channel (Hospital), Patient Care Setting (Hospital, Home Care) - Forecast to 2021

Publisher Name :
Date: 06-Feb-2017
No. of pages: 256
Inquire Before Buying

The global injectable drug delivery market, in terms of value, is projected to reach USD 624.50 billion by 2021 from USD 362.38billion in 2016, at a CAGR of 11.5% during the forecast period.

The increase in the use of biologics, the increase in the prevalence of chronic diseases, the increasing occurrence of needle stick injuries, and the benefits of injections (convenience, ease of use, and reduced pain) have driven the growth of the injectable drug delivery market. These factors have increased the demand for devices such as safety syringes, prefilled syringes, and auto injectors. However, the growing use of alternative delivery methods, safety concerns, and risk of transmission of blood-borne infections may hinder the growth of the market.

The injectable drug delivery is segmented based on type, formulation packaging, therapeutic application, usage pattern, site of administration, distribution channel, facility of use, and regions. Injectable drug delivery market by distribution channel is further segmented into hospitals and pharma stores. Hospitals are expected to account for a large share in this market, as hospitals provide injectables for the inpatients as well as to the outpatients, owing to which there is maximum sale of injectable formulations and devices through the hospitals. In addition, it provides pharmacy care for inpatients as well as patients from other clinics, ambulatory centers, patients discharged from healthcare facilities, and those receiving home care.

The Injectable drug delivery market by facility of use is segmented into hospitals and clinics, home care settings, and other facilities of use. The hospitals and clinics segment is expected to account for the largest share of the market, primarily due to the rising incidence of chronic diseases such as diabetes and cancer which require a large number of injectables for their treatment.

Asia is expected to be the fastest growing region in the market from 2016 to 2021due to the rising incidence of chronic and autoimmune diseases, the rising aging population, and the high penetration of self-injection techniques &technologies in countries such as China, Japan, and India.

Prominent players in the injectable drug delivery market include Becton, Dickinson and Company (U.S.), Baxter International (U.S.), Pfizer (U.S.), Gerresheimer AG (Germany), Schott AG (Germany), Eli Lilly and Company (U.S.), and Terumo Corporation (Japan).

Research Coverage:

The report defines, describes, and forecasts the injectable drug delivery market on the basis of type, formulation packaging, therapeutic application, usage pattern, site of administration, distribution channel, and facility of use. It provides detailed information regarding the major factors influencing the growth of the market (drivers, restraints, opportunities, challenges). The study tracks and analyzes competitive developments such as joint ventures, mergers &acquisitions, product developments, and expansions in the injectable drug delivery market across four main regions, namely, North America, Asia, Europe, and the Rest of the World (RoW).

Reasons to buy the report:

The report provides clients market size information on various segments of the injectable drug delivery market. This report also provides access to the quantitative data on the market. This report covers –


  • Current and forecast assessment of the injectable drug delivery market

  • Country-wise assessment of each of the segments

  • Global market share analysis for major segments of the injectable drug delivery market

  • Adoption Trends of injectable drug delivery for major geographic markets

  • Five-year coverage of strategic developments of top players in the injectable drug delivery market

  • Product Portfolio mapping of leading players in the injectable drug delivery market

Injectable Drug Delivery Market by Type (Device, Formulation), Therapeutic (Cancer), Usage Pattern (Immunization), Administration (Skin, Musculoskeletal), Distribution Channel (Hospital), Patient Care Setting (Hospital, Home Care) - Forecast to 2021

Table of Contents

1 Introduction
1.1 Objectives of the Study
1.2 Market Definition
1.3 Market Scope
1.3.1 Markets Covered
1.3.2 Years Considered for the Study
1.4 Currency
1.5 Limitations
1.6 Stakeholders

2 Research Methodology
2.1 Market Size Estimation
2.2 Market Breakdown and Data Triangulation
2.3 Key Data From Secondary Sources
2.4 Key Data From Primary Sources
2.5 Assumptions for the Study

3 Executive Summary

4 Premium Insights
4.1 Market Overview
4.2 Injectable Drug Delivery Market, By Facility of Use
4.3 Geographic Analysis: By Site of Administration
4.4 Injectable Drug Delivery Market, By Formulation Packaging
4.5 Geographical Snapshot

5 Market Overview
5.1 Introduction
5.2 Market Dynamics
5.2.1 Drivers
5.2.1.1 Rising Prevalence of Chronic Diseases
5.2.1.2 Increase in Demand for Self-Injection Devices
5.2.1.3 Growth in the Biologics Market
5.2.1.4 Technological Advancements and New Product Launches
5.2.2 Restraints
5.2.2.1 Infections Associated With Needlestick Injuries
5.2.2.2 Product Recalls
5.2.3 Opportunities
5.2.3.1 Increase in Demand for Biosimilar and Generic Injectables
5.2.3.1.1 Biosimilars
5.2.3.1.2 Generic Injectables
5.2.3.2 Contraceptive Injectables
5.2.4 Challenge
5.2.4.1 Preference for Other Modes of Drug Delivery

6 Regulatory Scenario
6.1 Introduction
6.2 FDA and CE Approvals
6.3 The European Medicines Agency (EMA)
6.4 Clinical Trials

7 Injectable Drug Delivery Market, By Type
7.1 Introduction
7.2 Devices
7.2.1 Conventional Injection Devices
7.2.1.1 By Material
7.2.1.1.1 Glass
7.2.1.1.2 Plastic
7.2.1.2 By Product
7.2.1.2.1 Fillable Syringes
7.2.1.2.2 Prefilled Syringes
7.2.1.3 By Usability
7.2.1.3.1 Reusable Injection Devices
7.2.1.3.2 Disposable Injection Devices
7.2.2 Self-Injection Devices
7.2.2.1 Needle-Free Injectors
7.2.2.1.1 By Product
7.2.2.1.1.1 Fillable Needle-Free Injectors
7.2.2.1.1.2 Prefilled Needle-Free Injectors
7.2.2.1.2 By Technology
7.2.2.1.2.1 Jet-Based Needle-Free Injectors
7.2.2.1.2.2 Spring-Based Needle-Free Injectors
7.2.2.1.2.3 Laser-Powered Needle-Free Injectors
7.2.2.1.2.4 Vibration-Based Needle-Free Injectors
7.2.2.1.3 By Usability
7.2.2.1.3.1 Reusable Needle-Free Injectors
7.2.2.1.3.2 Disposable Needle-Free Injectors
7.2.2.2 Autoinjectors
7.2.2.2.1 By Product
7.2.2.2.1.1 Fillable Autoinjectors
7.2.2.2.1.2 Prefilled Autoinjectors
7.2.2.2.2 By Technology
7.2.2.2.2.1 Automated Autoinjectors
7.2.2.2.2.2 Manual Autoinjectors
7.2.2.2.3 By Design
7.2.2.2.3.1 Standardized Autoinjectors
7.2.2.2.3.2 Customized Autoinjectors
7.2.2.2.4 By Usability
7.2.2.2.4.1 Reusable Autoinjectors
7.2.2.2.4.2 Disposable Autoinjectors
7.2.2.3 Pen Injectors
7.2.2.3.1 By Product
7.2.2.3.1.1 Single-Chambered Pen Injectors
7.2.2.3.1.2 Dual-Chambered Pen Injectors
7.2.2.3.2 By Design
7.2.2.3.2.1 Standard Pen Injectors
7.2.2.3.2.2 Customized Pen Injectors
7.2.2.3.3 By Usability
7.2.2.3.3.1 Reusable Pen Injectors
7.2.2.3.3.2 Disposable Pen Injectors
7.2.2.4 Wearable Injectors
7.2.2.5 Other Devices
7.3 Formulations
7.3.1 Conventional Drug Delivery Formulations
7.3.1.1 Solutions
7.3.1.2 Reconstituted/Lyophilized Formulations
7.3.1.3 Suspensions
7.3.1.4 Emulsions
7.3.2 Novel Drug Delivery Formulations
7.3.2.1 Colloidal Dispersions
7.3.2.1.1 Niosomes
7.3.2.1.2 Liposomes
7.3.2.1.3 Polymeric/Mixed Micelles
7.3.2.1.4 Nanoparticles
7.3.2.1.4.1 Solid-Lipid Nanoparticles
7.3.2.1.4.2 Nanosuspensions
7.3.2.1.4.3 Nanoemulsions
7.3.2.2 Microparticles
7.3.2.2.1 Microspheres
7.3.2.2.2 Microcapsules
7.3.3 Long-Acting Injection Formulations

8 Injectable Drug Delivery Market, By Formulation Packaging
8.1 Introduction
8.2 Ampules
8.3 Vials
8.4 Cartridges
8.5 Bottles

9 Injectable Drug Delivery Market, By Therapeutic Application
9.1 Introduction
9.2 Autoimmune Diseases
9.2.1 Rheumatoid Arthritis
9.2.2 Multiple Sclerosis (MS)
9.2.3 Crohn’s Disease
9.2.4 Psoriasis
9.2.5 Other Autoimmune Diseases
9.3 Hormonal Disorders
9.3.1 Diabetes
9.3.2 Anemia
9.3.3 Reproductive Health Disease
9.3.4 Antithrombotic/Thrombolytic Therapy
9.3.5 Osteoporosis
9.3.6 Growth Hormone Deficiency (GHD)
9.4 Orphan Diseases
9.5 Cancer
9.6 Other Therapeutic Applications
9.6.1 Pain Management
9.6.2 Allergies
9.6.3 Aesthetic Treatment
9.6.4 Hepatitis C
9.6.5 Hemophilia

10 Injectable Drug Delivery Market, By Usage Pattern
10.1 Introduction
10.2 Curative Care
10.3 Immunization
10.4 Others

11 Injectable Drug Delivery Market, By Site of Administration
11.1 Introduction
11.2 Skin (Intradermal and Subcutaneous)
11.3 Circulatory/Musculoskeletal System (Intravenous, Intracardiac, Intramuscular, and Intraperitoneal)
11.4 Organs (Intravitreal and Intra-Articular)
11.5 Central Nervous System (Intracerebral and Intrathecal)

12 Injectable Drug Delivery Market, By Distribution Channel
12.1 Introduction
12.2 Hospitals
12.3 Retail Pharmacy Stores

13 Injectable Drug Delivery Market, By Facility of Use
13.1 Introduction
13.2 Hospitals and Clinics
13.3 Home Care Settings
13.4 Other Facilities of Use

14 Injectable Drug Delivery Market, By Region
14.1 Introduction
14.2 North America
14.2.1 U.S.
14.2.2 Canada
14.3 Europe
14.3.1 Germany
14.3.2 France
14.3.3 U.K.
14.3.4 Italy
14.3.5 Spain
14.3.6 Rest of Europe (RoE)
14.4 Asia
14.4.1 China
14.4.2 Japan
14.4.3 India
14.4.4 Rest of Asia
14.5 Rest of the World (RoW)

15 Competitive Landscape
15.1 Overview
15.2 Market Share Analysis
15.3 Competitive Situation and Trends
15.3.1 Partnerships, Agreements, and Collaborations
15.3.2 Product Launches, Approvals, and Enhancements
15.3.3 Expansions
15.3.4 Acquisitions

16 Company Profiles
(Introduction, Products & Services, Strategy, & Analyst Insights, Developments, MnM View)*
16.1 Introduction
16.2 Baxter International, Inc.
16.3 Becton, Dickinson and Company
16.4 Gerresheimer AG
16.5 Pfizer, Inc.
16.6 Schott AG
16.7 ELI Lilly and Company
16.8 Sandoz (A Division of Novartis AG)
16.9 Terumo Corporation
16.10 Teva Pharmaceutical Industries Ltd.

*Details on Marketsandmarkets View, Introduction, Product & Services, Strategy, & Analyst Insights, New Developments Might Not Be Captured in Case of Unlisted Companies.

17 Appendix
17.1 Insights From Industry Experts
17.2 Discussion Guide
17.3 Other Recent Developments
17.4 Available Customizations
17.5 Knowledge Store: Marketsandmarkets’ Subscription Portal
17.6 RT: Real-Time Market Intelligence
17.7 Related Reports
17.8 Author Details

List of Tables

Table 1 Product Recalls (2013–2015)
Table 2 Injectable Drugs Going Off-Patent in the U.S.
Table 3 List of Regulatory Authorities in Major Countries
Table 4 List of FDA Approved in the Market (2015-2016)
Table 5 Injectable Drugs in Phase Iii Clinical Trials
Table 6 Product Recalls (2015-2016)
Table 7 Injectable Drug Delivery Market Size, By Type, 2014–2021 (USD Billion)
Table 8 Injectable Drug Delivery Devices Market Size, By Type, 2014–2021 (USD Billion)
Table 9 Injectable Drug Delivery Devices Market Size, By Region, 2014–2021 (USD Billion)
Table 10 Conventional Injection Devices Market Size, By Region, 2014–2021 (USD Billion)
Table 11 Conventional Injection Devices Market Size, By Material, 2014–2021 (USD Billion)
Table 12 Conventional Glass Injection Devices Market Size, By Region, 2014–2021 (USD Billion)
Table 13 Conventional Plastic Injection Devices Market Size, By Region, 2014–2021 (USD Billion)
Table 14 Conventional Injection Devices Market Size, By Product, 2014–2021 (USD Billion)
Table 15 Conventional Fillable Injection Devices Market Size, By Region, 2014–2021 (USD Billion)
Table 16 Conventional Prefilled Injection Devices Market Size, By Region, 2014–2021 (USD Billion)
Table 17 Conventional Injection Devices Market Size, By Usability, 2014–2021 (USD Billion)
Table 18 Conventional Reusable Injection Devices Market Size, By Region, 2014–2021 (USD Billion)
Table 19 Conventional Disposable Injection Devices Market Size, By Region, 2014–2021 (USD Billion)
Table 20 Self-Injection Devices Market Size, By Type, 2014–2021 (USD Billion)
Table 21 Self-Injection Devices Market Size, By Region, 2014–2021 (USD Billion)
Table 22 Needle-Free Injectors Market Size, By Region, 2014–2021 (USD Billion)
Table 23 Needle-Free Injectors Market Size, By Product, 2014–2021 (USD Billion)
Table 24 Fillable Needle-Free Injectors Market Size, By Region, 2014–2021 (USD Billion)
Table 25 Prefilled Needle-Free Injectors Market Size, By Region, 2014–2021 (USD Billion)
Table 26 Needle-Free Injectors Market Size, By Technology, 2014–2021 (USD Million)
Table 27 List of Some of the Needle-Free Jet Injectors Available in the Market
Table 28 Jet-Based Needle-Free Injectors Market Size, By Region, 2014–2021 (USD Billion)
Table 29 List of Some of the Needle-Free Spring-Based Injectors Available in the Market
Table 30 Spring-Based Needle-Free Injectors Market Size, By Region, 2014–2021 (USD Billion)
Table 31 Laser-Powered Needle-Free Injectors Market Size, By Region, 2014–2021 (USD Million)
Table 32 Vibration-Based Needle-Free Injectors Market Size, By Region, 2014–2021 (USD Million)
Table 33 Needle-Free Injectors Market Size, By Usability, 2014–2021 (USD Billion)
Table 34 Reusable Needle-Free Injectors Market Size, By Region, 2014–2021 (USD Billion)
Table 35 Disposable Needle-Free Injectors Market Size, By Region, 2014–2021 (USD Billion)
Table 36 Autoinjectors Market Size, By Region, 2014–2021 (USD Billion)
Table 37 Autoinjectors Market Size, By Product, 2014–2021 (USD Billion)
Table 38 Fillable Autoinjectors Market Size, By Region, 2014–2021 (USD Million)
Table 39 Prefilled Autoinjectors Market Size, By Region, 2014–2021 (USD Million)
Table 40 Autoinjectors Market Size, By Technology, 2014–2021 (USD Billion)
Table 41 Automated Autoinjectors Market Size, By Region, 2014–2021 (USD Billion)
Table 42 Manual Autoinjectors Market Size, By Region, 2014–2021 (USD Billion)
Table 43 Autoinjectors Market Size, By Design, 2014–2021 (USD Billion)
Table 44 Standardized Autoinjectors Market Size, By Region, 2014–2021 (USD Billion)
Table 45 Customized Autoinjectors Market Size, By Region, 2014–2021 (USD Billion)
Table 46 Autoinjector Market Size, By Usability, 2014–2021 (USD Billion)
Table 47 Reusable Autoinjectors Market Size, By Region, 2014–2021 (USD Billion)
Table 48 Disposable Autoinjectors Market Size, By Region, 2014–2021 (USD Billion)
Table 49 Pen Injectors Market Size, By Region, 2014–2021 (USD Billion)
Table 50 Commercially Available Pen Injectors
Table 51 Pen Injectors Market Size, By Product, 2014–2021 (USD Billion)
Table 52 Single-Chambered Pen Injectors Market Size, By Region, 2014–2021 (USD Billion)
Table 53 Commercially Available Dual-Chambered Pen Injectors
Table 54 Dual-Chambered Pen Injectors Market Size, By Region, 2014–2021 (USD Billion)
Table 55 Pen Injectors Market Size, By Design, 2014–2021 (USD Billion)
Table 56 Standard Pen Injectors Market Size, By Region, 2014–2021 (USD Billion)
Table 57 Customized Pen Injectors Market Size, By Region, 2014–2021 (USD Billion)
Table 58 Pen Injectors Market Size, By Usability, 2014–2021 (USD Billion)
Table 59 Reusable Pen Injectors Market Size, By Region, 2014–2021 (USD Billion)
Table 60 Disposable Pen Injectors Market Size, By Region, 2014–2021 (USD Billion)
Table 61 Wearable Injectors Market Size, By Region, 2014–2021 (USD Million)
Table 62 Other Devices Market Size, By Region, 2014–2021 (USD Billion)
Table 63 Injectable Drug Delivery Formulations Market Size, By Type, 2014–2021 (USD Billion)
Table 64 Injectable Drug Delivery Formulations Market Size, By Region, 2014–2021 (USD Billion)
Table 65 Conventional Drug Delivery Formulations Market Size, By Type, 2014–2021 (USD Billion)
Table 66 Conventional Drug Delivery Formulations Market Size, By Region, 2014–2021 (USD Billion)
Table 67 Solutions Market Size, By Region, 2014–2021 (USD Billion)
Table 68 Reconstituted/Lyophilized Formulations Market Size, By Region, 2014–2021 (USD Billion)
Table 69 Suspensions Market Size, By Region, 2014–2021 (USD Billion)
Table 70 Emulsions Market Size, By Region, 2014–2021 (USD Billion)
Table 71 Novel Drug Delivery Formulations Market Size, By Type, 2014–2021 (USD Billion)
Table 72 Novel Drug Delivery Formulations Market Size, By Region, 2014–2021 (USD Billion)
Table 73 Colloidal Dispersions Market Size, By Type, 2014–2021 (USD Billion)
Table 74 Colloidal Dispersions Market Size, By Region, 2014–2021 (USD Billion)
Table 75 Niosomes Market Size, By Region, 2014–2021 (USD Billion)
Table 76 Liposomes Market Size, By Region, 2014–2021 (USD Billion)
Table 77 Polymeric/Mixed Micelles Market Size, By Region, 2014–2021 (USD Billion)
Table 78 Nanoparticles Market Size, By Type, 2014–2021 (USD Billion)
Table 79 Nanoparticles Market Size, By Region, 2014–2021 (USD Billion)
Table 80 Solid-Lipid Nanoparticles Market Size, By Region, 2014–2021 (USD Billion)
Table 81 Nanosuspensions Market Size, By Region, 2014–2021 (USD Billion)
Table 82 Nanoemulsions Market Size, By Region, 2014–2021 (USD Million)
Table 83 Microparticles Market Size, By Type, 2014–2021 (USD Billion)
Table 84 Microparticles Market Size, By Region, 2014–2021 (USD Billion)
Table 85 Microspheres Market Size, By Region, 2014–2021 (USD Billion)
Table 86 Microcapsules Market Size, By Region, 2014–2021 (USD Billion)
Table 87 Long-Acting Injection Formulations Market Size, By Region, 2014–2021 (USD Billion)
Table 88 Injectable Drug Delivery Market Size, By Formulation Packaging, 2014–2021 (USD Billion)
Table 89 Injectable Drug Delivery Market Size for Formulation Packaging, By Region, 2014–2021 (USD Billion)
Table 90 Injectable Drug Delivery Market Size for Ampules, By Region, 2014–2021 (USD Billion)
Table 91 Injectable Drug Delivery Market Size for Vials, By Region, 2014–2021 (USD Billion)
Table 92 Injectable Drug Delivery Market Size for Cartridges, By Region, 2014–2021 (USD Billion)
Table 93 Injectable Drug Delivery Market Size for Bottles, By Region, 2014–2021 (USD Billion)
Table 94 Injectable Drug Delivery Market Size, By Therapeutic Application, 2014–2021 (USD Billion)
Table 95 Injectable Drug Delivery Market Size for Autoimmune Diseases, By Indication, 2014–2021 (USD Billion)
Table 96 Injectable Drug Delivery Market Size for Autoimmune Diseases, By Region, 2014–2021 (USD Billion)
Table 97 Injectable Drug Delivery Market Size for Rheumatoid Arthritis, By Region, 2014–2021 (USD Billion)
Table 98 Injectable Drug Delivery Market Size for Multiple Sclerosis, By Region, 2014–2021 (USD Billion)
Table 99 Market Size for Crohn’s Disease, By Region, 2014–2021 (USD Billion)
Table 100 Injectable Drug Delivery Market Size for Psoriasis, By Region, 2014–2021 (USD Billion)
Table 101 Market Size for Other Autoimmune Diseases, By Region, 2014–2021 (USD Billion)
Table 102 Injectable Drug Delivery Market Size for Hormonal Disorders, By Indication, 2014–2021 (USD Billion)
Table 103 Injectable Drug Delivery Market Size for Hormonal Disorders, By Region, 2014–2021 (USD Billion)
Table 104 Market Size for Diabetes, By Region, 2014–2021 (USD Billion)
Table 105 Injectable Drug Delivery Market Size for Anemia, By Region, 2014–2021 (USD Billion)
Table 106 Injectable Drug Delivery Market Size for Reproductive Health Disease, By Region, 2014–2021 (USD Billion)
Table 107 Market Size for Antithrombotic/Thrombolytic Therapy, By Region, 2014–2021 (USD Billion)
Table 108 Injectable Drug Delivery Market Size for Osteoporosis, By Region, 2014-2021 (USD Billion)
Table 109 Injectable Drug Delivery Market Size for Growth Hormone Deficiency, By Region, 2014-2021 (USD Billion)
Table 110 Injectable Drug Delivery Market Size for Orphan Diseases, By Region, 2014-2021 (USD Billion)
Table 111 Market Size for Cancer, By Region, 2014-2021 (USD Billion)
Table 112 Injectable Drug Delivery Market Size for Other Therapeutic Applications, By Indication, 2014-2021 (USD Billion)
Table 113 Injectable Drug Delivery Market Size for Other Therapeutic Applications, By Region, 2014-2021 (USD Billion)
Table 114 Injectable Drug Delivery Market Size for Pain Management, By Region, 2014-2021 (USD Billion)
Table 115 Market Size for Allergies, By Region, 2014-2021 (USD Billion)
Table 116 Injectable Drug Delivery Market Size for Aesthetic Treatments, By Region, 2014-2021 (USD Million)
Table 117 Injectable Drug Delivery Market Size for Hepatitis C, By Region, 2014-2021 (USD Billion)
Table 118 Injectable Drug Delivery Market Size for Hemophilia, By Region, 2014-2021 (USD Million)
Table 119 Injectable Drug Delivery Market Size, By Usage Pattern, 2014–2021 (USD Billion)
Table 120 Pipeline Curative Care Drugs (2016-2020)
Table 121 Market Size for Curative Care, By Region, 2014–2021 (USD Billion)
Table 122 Injectable Drug Delivery Market Size for Immunization, By Region, 2014–2021 (USD Billion)
Table 123 Injectable Drug Delivery Market Size for Other Usage Patterns, By Region, 2014–2021 (USD Billion)
Table 124 Market Size, By Site of Administration, 2014–2021 (USD Billion)
Table 125 Market for Injectable Drug Delivery Through Skin, By Region, 2014–2021 (USD Billion)
Table 126 Market for Injectable Drug Delivery Through Circulatory/Musculoskeletal System, By Region, 2014–2021 (USD Billion)
Table 127 Market for Injectable Drug Delivery Through Organs, By Region, 2014–2021 (USD Billion)
Table 128 Market for Injectable Drug Delivery Through Central Nervous System, By Region, 2014–2021 (USD Billion)
Table 129 Injectable Drug Delivery Market Size, By Distribution Channel, 2014–2021 (USD Billion)
Table 130 Injectable Drug Delivery Market Size for Hospitals, By Region, 2014–2021 (USD Million)
Table 131 Injectable Drug Delivery Market Size for Retail Pharmacy Stores, By Region, 2014–2021 (USD Million)
Table 132 Injectable Drug Delivery Market Size, By Facility of Use, 2014–2021 (USD Billion)
Table 133 Injectable Drug Delivery Market Size for Hospitals and Clinics, By Region, 2014–2021 (USD Billion)
Table 134 Market Size for Home Care Settings, By Region, 2014–2021 (USD Billion)
Table 135 Market Size for Other Facilities of Use, By Region, 2014–2021 (USD Billion)
Table 136 Injectable Drug Delivery Market Size, By Region, 2014-2021 (USD Billion)
Table 137 North America: Injectable Drug Delivery Market Size, By Country, 2014-2021 (USD Billion)
Table 138 North America: Market Size, By Type, 2014–2021 (USD Billion)
Table 139 North America: Market Size, By Device, 2014-2021 (USD Billion)
Table 140 North America: Market Size, By Formulation, 2014-2021 (USD Billion)
Table 141 North America: Market Size, By Therapeutic Application, 2014-2021 (USD Billion)
Table 142 North America: Injectable Drug Delivery Market Size, By Usage Pattern, 2014-2021 (USD Billion)
Table 143 North America: Market Size, By Site of Administration, 2014-2021 (USD Billion)
Table 144 North America: Market Size, By Facility of Use, 2014-2021 (USD Billion)
Table 145 North America: Market Size, By Formulation Packaging, 2014-2021 (USD Billion)
Table 146 North America: Injectable Drug Delivery Market Size, By Distribution Channel, 2014-2021 (USD Billion)
Table 147 U.S.: Injectable Drug Delivery Market Size, By Type, 2014-2021 (USD Billion)
Table 148 U.S.: Market Size, By Device, 2014-2021 (USD Billion)
Table 149 U.S.: Injectable Drug Delivery Market Size, By Formulation, 2014-2021 (USD Billion)
Table 150 U.S.: Market Size, By Therapeutic Application, 2014-2021 (USD Billion)
Table 151 U.S.: Injectable Drug Delivery Market Size, By Usage Pattern, 2014-2021 (USD Billion)
Table 152 U.S.: Market Size, By Site of Administration, 2014-2021 (USD Billion)
Table 153 U.S.: Market Size, By Facility of Use, 2014-2021 (USD Billion)
Table 154 U.S.: Market Size, By Formulation Packaging, 2014-2021 (USD Billion)
Table 155 U.S.: Injectable Drug Delivery Market Size, By Distribution Channel, 2014-2021 (USD Billion)
Table 156 List of Injectables Launched in Canada (2014-2015)
Table 157 Canada: Injectable Drug Delivery Market Size, By Type, 2014-2021 (USD Billion)
Table 158 Canada: Market Size, By Device, 2014-2021 (USD Billion)
Table 159 Canada: Market Size, By Formulation, 2014-2021 (USD Billion)
Table 160 Canada: Market Size, By Therapeutic Application, 2014-2021 (USD Billion)
Table 161 Canada: Market Size, By Usage Pattern, 2014-2021 (USD Billion)
Table 162 Canada: Market Size, By Site of Administration, 2014-2021 (USD Billion)
Table 163 Canada: Injectable Drug Delivery Market Size, By Facility of Use, 2014-2021 (USD Billion)
Table 164 Canada: Market Size, By Formulation Packaging, 2014-2021 (USD Billion)
Table 165 Canada: Market Size, By Distribution Channel, 2014-2021 (USD Billion)
Table 166 Europe: Injectable Drug Delivery Market Size, By Country, 2014-2021 (USD Billion)
Table 167 Europe: Market Size, By Type, 2014-2021 (USD Billion)
Table 168 Europe: Injectable Drug Delivery Market Size, By Device, 2014-2021 (USD Billion)
Table 169 Europe: Market Size, By Formulation, 2014-2021 (USD Billion)
Table 170 Europe: Injectable Drug Delivery Market Size, By Therapeutic Application, 2014-2021 (USD Billion)
Table 171 Europe: Market Size, By Usage Pattern, 2014-2021 (USD Billion)
Table 172 Europe: Market Size, By Site of Administration, 2014-2021 (USD Billion)
Table 173 Europe: Market Size, By Facility of Use, 2014-2021 (USD Billion)
Table 174 Europe: Market Size, By Formulation Packaging, 2014-2021 (USD Billion)
Table 175 Europe: Market Size, By Distribution Channel, 2014-2021 (USD Billion)
Table 176 Germany: Injectable Drug Delivery Market Size, By Type, 2014-2021 (USD Billion)
Table 177 Germany: Market Size, By Device, 2014-2021 (USD Billion)
Table 178 Germany: Market Size, By Formulation, 2014-2021 (USD Billion)
Table 179 Germany: Market Size, By Therapeutic Application, 2014-2021 (USD Billion)
Table 180 Germany: Injectable Drug Delivery Market Size, By Usage Pattern, 2014-2021 (USD Billion)
Table 181 Germany: Market Size, By Site of Administration, 2014-2021 (USD Billion)
Table 182 Germany: Injectable Drug Delivery Market Size, By Facility of Use, 2014-2021 (USD Billion)
Table 183 Germany: Market Size, By Formulation Packaging, 2014-2021 (USD Billion)
Table 184 Germany: Injectable Drug Delivery Market Size, By Distribution Channel, 2014-2021 (USD Billion)
Table 185 France: Injectable Drug Delivery Market Size, By Type, 2014-2021 (USD Billion)
Table 186 France: Market Size, By Device, 2014-2021 (USD Billion)
Table 187 France: Injectable Drug Delivery Market Size, By Formulation, 2014-2021 (USD Billion)
Table 188 France: Market Size, By Therapeutic Application, 2014-2021 (USD Billion)
Table 189 France: Injectable Drug Delivery Market Size, By Usage Pattern, 2014-2021 (USD Billion)
Table 190 France: Market Size, By Site of Administration, 2014-2021 (USD Billion)
Table 191 France: Injectable Drug Delivery Market Size, By Facility of Use, 2014-2021 (USD Billion)
Table 192 France: Market Size, By Formulation Packaging, 2014-2021 (USD Billion)
Table 193 France: Market Size, By Distribution Channel, 2014-2021 (USD Billion)
Table 194 U.K.: Injectable Drug Delivery Market Size, By Type, 2014-2021 (USD Billion)
Table 195 U.K.: Market Size, By Device, 2014-2021 (USD Billion)
Table 196 U.K.: Injectable Drug Delivery Market Size, By Formulation, 2014-2021 (USD Billion)
Table 197 U.K.: Market Size, By Therapeutic Application, 2014-2021 (USD Billion)
Table 198 U.K.: Market Size, By Usage Pattern, 2014-2021 (USD Billion)
Table 199 U.K.: Injectable Drug Delivery Market Size, By Site of Administration, 2014-2021 (USD Billion)
Table 200 U.K.: Market Size, By Facility of Use, 2014-2021 (USD Billion)
Table 201 U.K.: Market Size, By Formulation Packaging, 2014-2021 (USD Billion)
Table 202 U.K.: Market Size, By Distribution Channel, 2014-2021 (USD Billion)
Table 203 Italy: Injectable Drug Delivery Market Size, By Type, 2014-2021 (USD Billion)
Table 204 Italy: Market Size, By Device, 2014-2021 (USD Million)
Table 205 Italy: Injectable Drug Delivery Market Size, By Formulation, 2014-2021 (USD Billion)
Table 206 Italy: Market Size, By Therapeutic Application, 2014-2021 (USD Billion)
Table 207 Italy: Market Size, By Usage Pattern, 2014-2021 (USD Billion)
Table 208 Italy: Injectable Drug Delivery Market Size, By Site of Administration, 2014-2021 (USD Billion)
Table 209 Italy: Market Size, By Facility of Use, 2014-2021 (USD Billion)
Table 210 Italy: Injectable Drug Delivery Market Size, By Formulation Packaging, 2014-2021 (USD Billion)
Table 211 Italy: Injectable Drug Delivery Market Size, By Distribution Channel, 2014-2021 (USD Billion)
Table 212 Spain: Injectable Drug Delivery Market Size, By Type, 2014-2021 (USD Billion)
Table 213 Spain: Market Size, By Device, 2014-2021 (USD Million)
Table 214 Spain: Market Size, By Formulation, 2014-2021 (USD Billion)
Table 215 Spain: Market Size, By Therapeutic Application, 2014-2021 (USD Billion)
Table 216 Spain: Market Size, By Usage Pattern, 2014-2021 (USD Billion)
Table 217 Spain: Market Size, By Site of Administration, 2014-2021 (USD Billion)
Table 218 Spain: Market Size, By Facility of Use, 2014-2021 (USD Billion)
Table 219 Spain: Market Size, By Formulation Packaging, 2014-2021 (USD Billion)
Table 220 Spain: Injectable Drug Delivery Market Size, By Distribution Channel, 2014-2021 (USD Billion)
Table 221 RoE: Injectable Drug Delivery Market Size, By Type, 2014-2021 (USD Billion)
Table 222 RoE: Market Size, By Device, 2014-2021 (USD Billion)
Table 223 RoE: Market Size, By Formulation, 2014-2021 (USD Billion)
Table 224 RoE: Injectable Drug Delivery Market Size, By Therapeutic Application, 2014-2021 (USD Billion)
Table 225 RoE: Market Size, By Usage Pattern, 2014-2021 (USD Billion)
Table 226 RoE: Market Size, By Site of Administration, 2014-2021 (USD Billion)
Table 227 RoE: Injectable Drug Delivery Market Size, By Facility of Use, 2014-2021 (USD Billion)
Table 228 RoE: Market Size, By Formulation Packaging, 2014-2021 (USD Billion)
Table 229 RoE: Injectable Drug Delivery Market Size, By Distribution Channel, 2014-2021 (USD Billion)
Table 230 Asia: Injectable Drug Delivery Market Size, By Country, 2014-2021 (USD Billion)
Table 231 Asia: Market Size, By Type, 2014-2021 (USD Billion)
Table 232 Asia: Market Size, By Device, 2014-2021 (USD Billion)
Table 233 Asia: Market Size, By Formulation, 2014-2021 (USD Billion)
Table 234 Asia: Market Size, By Therapeutic Application, 2014-2021 (USD Billion)
Table 235 Asia: Market Size, By Usage Pattern, 2014-2021 (USD Billion)
Table 236 Asia: Market Size, By Site of Administration, 2014-2021 (USD Billion)
Table 237 Asia: Market Size, By Facility of Use, 2014-2021 (USD Billion)
Table 238 Asia: Market Size, By Formulation Packaging, 2014-2021 (USD Billion)
Table 239 Asia: Injectable Drug Delivery Market Size, By Distribution Channel, 2014-2021 (USD Billion)
Table 240 China: Injectable Drug Delivery Market Size, By Type, 2014–2021 (USD Billion)
Table 241 China: Market Size, By Device, 2014-2021 (USD Billion)
Table 242 China: Market Size, By Formulation, 2014-2021 (USD Billion)
Table 243 China: Market Size, By Therapeutic Application, 2014-2021 (USD Billion)
Table 244 China: Market Size, By Usage Pattern, 2014-2021 (USD Billion)
Table 245 China: Market Size, By Site of Administration, 2014-2021 (USD Billion)
Table 246 China: Market Size, By Facility of Use, 2014-2021 (USD Billion)
Table 247 China: Injectable Drug Delivery Market Size, By Formulation Packaging, 2014-2021 (USD Billion)
Table 248 China: Market Size, By Distribution Channel, 2014-2021 (USD Billion)
Table 249 Japan: Injectable Drug Delivery Market Size, By Type, 2014–2021 (USD Billion)
Table 250 Japan: Market Size, By Device, 2014-2021 (USD Billion)
Table 251 Japan: Injectable Drug Delivery Market Size, By Formulation, 2014-2021 (USD Billion)
Table 252 Japan: Market Size, By Therapeutic Application, 2014-2021 (USD Billion)
Table 253 Japan: Market Size, By Usage Pattern, 2014-2021 (USD Billion)
Table 254 Japan: Injectable Drug Delivery Market Size, By Site of Administration, 2014-2021 (USD Billion)
Table 255 Japan: Market Size, By Facility of Use, 2014-2021 (USD Billion)
Table 256 Japan: Injectable Drug Delivery Market Size, By Formulation Packaging, 2014-2021 (USD Billion)
Table 257 Japan: Market Size, By Distribution Channel, 2014-2021 (USD Billion)
Table 258 India: Injectable Drug Delivery Market Size, By Type, 2014–2021 (USD Billion)
Table 259 India: Market Size, By Device, 2014-2021 (USD Billion)
Table 260 India: Market Size, By Formulation, 2014-2021 (USD Billion)
Table 261 India: Market Size, By Therapeutic Application, 2014-2021 (USD Billion)
Table 262 India: Market Size, By Usage Pattern, 2014-2021 (USD Billion)
Table 263 India: Market Size, By Site of Administration, 2014-2021 (USD Billion)
Table 264 India: Market Size, By Facility of Use, 2014-2021 (USD Billion)
Table 265 India: Market Size, By Formulation Packaging, 2014-2021 (USD Billion)
Table 266 India: Injectable Drug Delivery Market Size, By Distribution Channel, 2014-2021 (USD Billion)
Table 267 RoA: Injectable Drug Delivery Market Size, By Type, 2014–2021 (USD Billion)
Table 268 RoA: Market Size, By Device, 2014-2021 (USD Million)
Table 269 RoA: Market Size, By Formulation, 2014-2021 (USD Billion)
Table 270 RoA: Market Size, By Therapeutic Application, 2014-2021 (USD Billion)
Table 271 RoA: Market Size, By Usage Pattern, 2014-2021 (USD Million)
Table 272 RoA: Market Size, By Site of Administration, 2014-2021 (USD Billion)
Table 273 RoA: Market Size, By Facility of Use, 2014-2021 (USD Billion)
Table 274 RoA: Market Size, By Formulation Packaging, 2014-2021 (USD Billion)
Table 275 RoA: Market Size, By Distribution Channel, 2014-2021 (USD Billion)
Table 276 RoW: Market Size, By Type, 2014-2021 (USD Billion)
Table 277 RoW: Market Size, By Device, 2014-2021 (USD Billion)
Table 278 RoW: Market Size, By Formulation, 2014-2021 (USD Billion)
Table 279 RoW: Market Size, By Therapeutic Application, 2014-2021 (USD Billion)
Table 280 RoW: Market Size, By Usage Pattern, 2014-2021 (USD Billion)
Table 281 RoW: Market Size, By Site of Administration, 2014–2021 (USD Billion)
Table 282 RoW: Injectable Drug Delivery Market Size, By Facility of Use, 2014-2021 (USD Billion)
Table 283 RoW: Market Size, By Formulation Packaging, 2014-2021 (USD Billion)
Table 284 RoW: Injectable Drug Delivery Market Size, By Distribution Channel, 2014-2021 (USD Billion)
Table 285 Partnerships, Agreements, and Collaborations (2013–2016)
Table 286 Product Launches, Approvals, and Enhancements (2013–2016)
Table 287 Expansions (2013–2016)
Table 288 Acquisitions (2013–2016)

List of Figures

Figure 1 Injectable Drug Delivery Market
Figure 2 Research Design
Figure 3 Market Size Estimation: Bottom-Up Approach
Figure 4 Market Size Estimation: Top-Down Approach
Figure 5 Breakdown of Primary Interviews: By Company, Designation and Region
Figure 6 Data Triangulation Methodology
Figure 7 Injectable Drug Delivery Market Snapshot, By Formulation 2016 vs 2021 (USD Billion)
Figure 8 Injectable Drug Delivery Market, By Facility of Use 2016 vs 2021 (USD Billion)
Figure 9 Injectable Drug Delivery Market, By Therapeutic Application, 2016 vs 2021 (USD Billion)
Figure 10 Injectable Drug Delivery Market, By Region (2016-2021)
Figure 11 Increasing Use of Biologic Drugs and Rising Prevalence of Chronic Diseases to Drive Market Growth
Figure 12 Hospitals and Clinics to Dominate the Market in 2016
Figure 13 Skin Segment to Command the Largest Market Share in 2016
Figure 14 Ampules to Dominate the Injectable Drug Delivery Market, in 2016
Figure 15 China to Register Highest Growth Rate During the Forecast Period
Figure 16 Market Drivers, Restraints, Opportunities, and Challenges
Figure 17 North America: Market Snapshot
Figure 18 Europe: Market Snapshot
Figure 19 Asia: Market Snapshot
Figure 20 Rest of the World: Market Snapshot
Figure 21 Key Players Adopted Inorganic Growth Strategies Between 2013 and 2016
Figure 22 Market Evolution Framework, 2013–2016
Figure 23 Global Market Share Analysis, 2015
Figure 24 Battle for Market Share: Partnerships, Agreements, and Collaborations are the Key Strategies Adopted By Market Players
Figure 25 Geographic Benchmarking of Top 5 Players
Figure 26 Baxter International, Inc.: Company Snapshot (2015)
Figure 27 Becton, Dickinson and Company: Company Snapshot (2015)
Figure 28 Gerresheimer AG: Company Snapshot (2015)
Figure 29 Pfizer, Inc.: Company Snapshot (2015)
Figure 30 Schott AG: Company Snapshot (2015)
Figure 31 ELI Lilly and Company: Company Snapshot (2015)
Figure 32 Sandoz: Company Snapshot (2015)
Figure 33 Terumo Corporation: Company Snapshot (2015)
Figure 34 Teva Pharmaceutical Industries Ltd.: Company Snapshot (2015)

  • United States Inhalation Therapy Nebulizer Market Report 2017
    Published: 19-Sep-2017        Price: US 3800 Onwards        Pages: 97
    In this report, the United States Inhalation Therapy Nebulizer market is valued at USD XX million in 2016 and is expected to reach USD XX million by the end of 2022, growing at a CAGR of XX% between 2016 and 2022. Geographically, this report splits the United States market into seven regions: - The West - Southwest - The Middle Atlantic - New England - The South - The Midwest with sales (volume), revenue (value), market share and gr......
  • Global Drug Delivery Devices Market Research Report 2017
    Published: 15-Sep-2017        Price: US 2900 Onwards        Pages: 118
    In this report, the global Drug Delivery Devices market is valued at USD XX million in 2016 and is expected to reach USD XX million by the end of 2022, growing at a CAGR of XX% between 2016 and 2022. Geographically, this report is segmented into several key Regions, with production, consumption, revenue (million USD), market share and growth rate of Drug Delivery Devices in these regions, from 2012 to 2022 (forecast), covering - North America - Europe - China......
  • Global Inhalation Therapy Nebulizer Sales Market Report 2017
    Published: 15-Sep-2017        Price: US 4000 Onwards        Pages: 109
    In this report, the global Inhalation Therapy Nebulizer market is valued at USD XX million in 2016 and is expected to reach USD XX million by the end of 2022, growing at a CAGR of XX% between 2016 and 2022. Geographically, this report split global into several key Regions, with sales (K Units), revenue (Million USD), market share and growth rate of Inhalation Therapy Nebulizer for these regions, from 2012 to 2022 (forecast), covering - United States - China - ......
  • Injectable Drug Delivery - Medical Devices Pipeline Assessment, 2017
    Published: 12-Sep-2017        Price: US 4000 Onwards        Pages: 613
    GlobalData's Medical Devices sector report, "Injectable Drug Delivery Medical Devices Pipeline Assessment, 2017" provides an overview of Injectable Drug Delivery currently in pipeline stage. The report provides comprehensive information on the pipeline products with comparative analysis of the products at various stages of development. The report reviews major players involved in the pipeline product development. It also provides information about clinical trials in progress, which in......
  • Global Metered Dose Inhaler Devices Market Professional Survey Report 2017
    Published: 11-Sep-2017        Price: US 3500 Onwards        Pages: 112
    This report studies Metered Dose Inhaler Devices in Global market, especially in North America, China, Europe, Southeast Asia, Japan and India, with production, revenue, consumption, import and export in these regions, from 2012 to 2016, and forecast to 2022. This report focuses on top manufacturers in global market, with production, price, revenue and market share for each manufacturer, covering - GlaxoSmithKline - AstraZeneca - Boehringer Ingelheim - ......
  • Global Drug Delivery Devices Market Professional Survey Report 2017
    Published: 07-Sep-2017        Price: US 3500 Onwards        Pages: 128
    This report studies Drug Delivery Devices in Global market, especially in North America, China, Europe, Southeast Asia, Japan and India, with production, revenue, consumption, import and export in these regions, from 2012 to 2016, and forecast to 2022. This report focuses on top manufacturers in global market, with production, price, revenue and market share for each manufacturer, covering - Cipla - Baxter International - Nipro Corporation - Roche......
  • Global and Regional Drug Delivery Devices Market Research Report 2017
    Published: 06-Sep-2017        Price: US 3500 Onwards        Pages: 185
    Summary Drug delivery devices are used to delivery drug to the specific part of body or cure some disease. With the help of drug delivery devices, drug can efficiently reach the target and be in a controlled manner. Generally, there are several of drug delivery devices corresponding to the medicine taken ways, such as syringe, spray bottle and implantable drug delivery devices etc. Market Segment as follows: By Region - Asia-Pacific - North Amer......
  • 2017-2022 Global Top Countries Drug Delivery Devices Market Report
    Published: 05-Sep-2017        Price: US 4960 Onwards        Pages: 162
    "This report will be delivered in 2-3 business days after the order is placed." The Global Drug Delivery Devices market size will be XX million (USD) in 2022, from the XX million (USD) in 2016, with a CAGR (Compound Annual Growth Rate) XX% from 2016 to 2022. This report studies Drug Delivery Devices in Global market, especially in United States, Canada, Mexico, Germany, France, UK, Italy, Russia, China, Japan, India, Korea, Southeast Asia, Australia......
  • 2017 Top 5 Drug Delivery Devices Manufacturers in North America, Europe, Asia-Pacific, South America, Middle East and Africa
    Published: 05-Sep-2017        Price: US 4960 Onwards        Pages: 162
    "This report will be delivered in 2-3 business days after the order is placed." The Global Drug Delivery Devices market size will be XX million (USD) in 2022, from the XX million (USD) in 2016, with a CAGR (Compound Annual Growth Rate) XX% from 2016 to 2022. This report studies Drug Delivery Devices in Global market, especially in North America, Europe, Asia-Pacific, South America, Middle East and Africa, focuses on the top 5 Drug Delivery Devices P......
  • SERVICES
    Value for Money
    We believe in "optimum utilization of available budget and resources". While servicing our clients' (your) market research requirements, we keep the same approach in focus to help you get the best value for your $$s.
    Ever Growing Inventory
    Ranging from the smallest feasible / required data (datasheets, data facts, SWOT analysis, company profiles, etc) to full research reports that help you make decisions, our inventory is updated almost on a daily basis with the latest industry reports from domain experts that track more than 5000 niche sectors.
    One Stop Solution
    Need a custom research report on medical devices market? Require all available business intelligence on 3D printing industry? Exploring F&B sector of a particular country/region? RnRMarketResearch.com is your one-stop-solution to all market intelligence needs. We not only offer custom research and consulting services, we also "bundle" reports to meet your needs and help you fetch the data analysis you require for your business.
    Dedicated Client Engagement
    Not limited to only "finding" relevant reports for you, our client engagement team dedicates its efforts to understand your "business need" and accordingly maps available research data to help you move forward. Call "your" client engagement executive any time of your day and get your questions answered in order to make the correct business decision.
    Saving Time and Efforts
    Simply share your research requirement details with us and let us do all the hard work to find required intelligence for you. When you add up our "one stop solution" and "dedicated client engagement" services mentioned above, you obviously know the time and effort saving you do by working with us.
    Payment Flexibility
    Working with Fortune 500 organizations, we understand the importance of being flexible for payments. Share your payment terms with us and we will surely match up to them to ensure you get access to required business intelligence data without having to wait for the payment to be done.
    Post-Purchase Research Support
    Have questions after reading a report / datasheet bought through us? Not sure about the methodology used for data available in the research? Talk to us / Share your questions with us and if required, we will connect you with the analyst(s)/author(s) of the report(s) and ensure you get satisfactory answers for the same. Need more data / analysis / report(s) on the topic of your research/project? The RnRMarketResearch.com team is here for you 24X7 to support you with your post-purchase requirements. Subscription Offers & Packages (Get in touch with us for more details - sales@rnrmarketresearch.com / +1 888 391 5441 )
    • Ad Hoc
    • Pay - as - you - go / Bucket Subscriptions
    • Fixed Cost for #of reports
    • Customize / Personalize as per your needs